Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-24 @ 4:02 PM
NCT ID:
NCT00627666
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of any 1 of the following:
* Acute leukemia
* Chronic myelogenous leukemia
* Myelodysplastic syndromes
* Must have an unrelated donor available who is matched for HLA-A and -B by serology and for DRB1 by molecular typing
PATIENT CHARACTERISTICS:
* Karnofsky performance status 70-100%
* Bilirubin \< 3.0 mg/dL
* Creatinine \< 2.0 mg/dL
* AST and ALT \< 3 times the upper limit of normal
* Not pregnant or nursing
* Ejection fraction ≥ 45% by MUGA scan or ECHO
* No major illness or organ failure
* No severe psychiatric disorder or mental deficiency that makes compliance with the treatment unlikely and informed consent impossible
PRIOR CONCURRENT THERAPY:
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
65 Years
Study:
NCT00627666
Study Brief:
Protocol Section:
NCT00627666